An Arrowhead Pharmaceuticals RNA drug has passed the regulatory bar for treating a disease that leads to dangerously high levels of fat in the blood, marking the first FDA approval for the company and ...
The announcement of a landmark deal with a pharmaceutical giant validates Arrowhead's technology. For reference, the TRiM platform is a key part of the investment case for the stock. Arrowhead's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results